EMA committee recommends marketing approval of AVT06, Alvotech's proposed biosimilar to Eylea
Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare …